Article Text
Commentary
Bringing science and advocacy together to address health needs of people who inject drugs
Statistics from Altmetric.com
Footnotes
Competing interests None declared.
Provenance and peer review Commissioned; internally peer reviewed.
Author note The views expressed in this article are those of the authors alone, and do not represent any policy or position of the US National Institutes of Health, the US Department of Health and Human Services, or any of its components.
Linked Articles
- Response
- Commentary
- Commentary
- Feature article
Read the full text or download the PDF:
Other content recommended for you
- Addressing ethical challenges in HIV prevention research with people who inject drugs
- ‘Wicked problems’, community engagement and the need for an implementation science for research ethics
- Young and invisible: a qualitative study of service engagement by people who inject drugs in India
- HIV among people who inject drugs in Central and Eastern Europe and Central Asia: a systematic review with implications for policy
- Health programmes and services addressing the prevention and management of infectious diseases in people who inject drugs in Canada: a systematic integrative review
- Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe) – a natural experiment (protocol)
- A longitudinal study of hepatitis C virus testing and infection status notification on behaviour change in people who inject drugs
- Cost-effectiveness of HCV case-finding for people who inject drugs via dried blood spot testing in specialist addiction services and prisons
- Evaluating Montréal’s harm reduction interventions for people who inject drugs: protocol for observational study and cost-effectiveness analysis
- A police education programme to integrate occupational safety and HIV prevention: protocol for a modified stepped-wedge study design with parallel prospective cohorts to assess behavioural outcomes